Quality of life in Parkinson’s disease patients: progression markers of mild to moderate stages
ABSTRACT Objective To investigate which factors are associated with the quality of life decline in Parkinson’s disease patients from mild to moderate stages. Methods The Unified Parkinson’s Disease Rating Scale and Parkinson’s Disease Questionnaire-39 were used to evaluate clinical/functional da...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Academia Brasileira de Neurologia (ABNEURO)
|
Series: | Arquivos de Neuro-Psiquiatria |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2017000800497&lng=en&tlng=en |
id |
doaj-0024fa99a66b4a33b1aff83f82440160 |
---|---|
record_format |
Article |
spelling |
doaj-0024fa99a66b4a33b1aff83f824401602020-11-24T22:41:32ZengAcademia Brasileira de Neurologia (ABNEURO)Arquivos de Neuro-Psiquiatria1678-422775849750210.1590/0004-282x20170091S0004-282X2017000800497Quality of life in Parkinson’s disease patients: progression markers of mild to moderate stagesRaissa Carla MoreiraMarise Bueno ZontaAna Paula Serra de AraújoVera Lúcia IsraelHélio A. G. TeiveABSTRACT Objective To investigate which factors are associated with the quality of life decline in Parkinson’s disease patients from mild to moderate stages. Methods The Unified Parkinson’s Disease Rating Scale and Parkinson’s Disease Questionnaire-39 were used to evaluate clinical/functional data and the quality of life. Results The markers of clinical/functional worsening were drooling (p < 0.004), need for assistance with hygiene (p = 0.02), greater freezing frequency (p = 0.042), bradykinesia (p = 0.031), greater intensity of the resting tremor (p = 0.035) and “pill rolling” (p = 0.001). The decline in quality of life was related to stigma (p = 0.043), greater impairment in cognition (p = 0.002), mobility (p = 0.013) and for daily living activities (p = 0.05), and was considered more significant in men, married, older individuals, and those with a longer time of disease. Conclusions The quality of life worsening markers at the moderate stage were related to stigma, worsening of cognition, and to greater impairment in mobility and daily living activities.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2017000800497&lng=en&tlng=enParkinson diseasequality of lifesurveys and questionnaires |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Raissa Carla Moreira Marise Bueno Zonta Ana Paula Serra de Araújo Vera Lúcia Israel Hélio A. G. Teive |
spellingShingle |
Raissa Carla Moreira Marise Bueno Zonta Ana Paula Serra de Araújo Vera Lúcia Israel Hélio A. G. Teive Quality of life in Parkinson’s disease patients: progression markers of mild to moderate stages Arquivos de Neuro-Psiquiatria Parkinson disease quality of life surveys and questionnaires |
author_facet |
Raissa Carla Moreira Marise Bueno Zonta Ana Paula Serra de Araújo Vera Lúcia Israel Hélio A. G. Teive |
author_sort |
Raissa Carla Moreira |
title |
Quality of life in Parkinson’s disease patients: progression markers of mild to moderate stages |
title_short |
Quality of life in Parkinson’s disease patients: progression markers of mild to moderate stages |
title_full |
Quality of life in Parkinson’s disease patients: progression markers of mild to moderate stages |
title_fullStr |
Quality of life in Parkinson’s disease patients: progression markers of mild to moderate stages |
title_full_unstemmed |
Quality of life in Parkinson’s disease patients: progression markers of mild to moderate stages |
title_sort |
quality of life in parkinson’s disease patients: progression markers of mild to moderate stages |
publisher |
Academia Brasileira de Neurologia (ABNEURO) |
series |
Arquivos de Neuro-Psiquiatria |
issn |
1678-4227 |
description |
ABSTRACT Objective To investigate which factors are associated with the quality of life decline in Parkinson’s disease patients from mild to moderate stages. Methods The Unified Parkinson’s Disease Rating Scale and Parkinson’s Disease Questionnaire-39 were used to evaluate clinical/functional data and the quality of life. Results The markers of clinical/functional worsening were drooling (p < 0.004), need for assistance with hygiene (p = 0.02), greater freezing frequency (p = 0.042), bradykinesia (p = 0.031), greater intensity of the resting tremor (p = 0.035) and “pill rolling” (p = 0.001). The decline in quality of life was related to stigma (p = 0.043), greater impairment in cognition (p = 0.002), mobility (p = 0.013) and for daily living activities (p = 0.05), and was considered more significant in men, married, older individuals, and those with a longer time of disease. Conclusions The quality of life worsening markers at the moderate stage were related to stigma, worsening of cognition, and to greater impairment in mobility and daily living activities. |
topic |
Parkinson disease quality of life surveys and questionnaires |
url |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2017000800497&lng=en&tlng=en |
work_keys_str_mv |
AT raissacarlamoreira qualityoflifeinparkinsonsdiseasepatientsprogressionmarkersofmildtomoderatestages AT marisebuenozonta qualityoflifeinparkinsonsdiseasepatientsprogressionmarkersofmildtomoderatestages AT anapaulaserradearaujo qualityoflifeinparkinsonsdiseasepatientsprogressionmarkersofmildtomoderatestages AT veraluciaisrael qualityoflifeinparkinsonsdiseasepatientsprogressionmarkersofmildtomoderatestages AT helioagteive qualityoflifeinparkinsonsdiseasepatientsprogressionmarkersofmildtomoderatestages |
_version_ |
1725702034491965440 |